New target for inhibition of bacterial RNA polymerase: 'switch region' (Q24634933)

Europe PubMed Central

title

New target for inhibition of bacterial RNA polymerase: 'switch region' (English)

0 references

Elena Sineva

6

0 references

Richard H. Ebright

object named as

Richard Y Ebright

5

0 references

Jayanta Mukhopadhyay

10

object named as

Jayanta Mukhopadhyay

0 references

author name string

Aashish Srivastava

1

0 references

Meliza Talaue

2

0 references

Shuang Liu

3

0 references

David Degen

4

0 references

Anirban Chakraborty

7

0 references

Sergey Y Druzhinin

8

0 references

Sujoy Chatterjee

9

0 references

Yon W Ebright

11

0 references

Alex Zozula

12

0 references

Juan Shen

13

0 references

Sonali Sengupta

14

0 references

Rui Rong Niedfeldt

15

0 references

Cai Xin

16

0 references

Takushi Kaneko

17

0 references

Herbert Irschik

18

0 references

Rolf Jansen

19

0 references

Stefano Donadio

20

0 references

Nancy Connell

21

0 references

Richard H Ebright

Current Opinion in Microbiology

22

0 references

language of work or name

English

0 references

publication date

October 2011

0 references

published in

0 references

volume

14

0 references

issue

5

0 references

page(s)

532-43

0 references

cites work

Structures of RNA polymerase-antibiotic complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

The RNA polymerase "switch region" is a target for inhibitors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Transcription inactivation through local refolding of the RNA polymerase structure

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Biological cost of rifampin resistance from the perspective of Staphylococcus aureus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Structural basis for transcription elongation by bacterial RNA polymerase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Structural mechanism for rifampicin inhibition of bacterial rna polymerase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Rifamycin-mode of action, resistance, and biosynthesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Role of individual drugs in the chemotherapy of tuberculosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Mechanism of bacterial transcription initiation: RNA polymerase - promoter binding, isomerization to initiation-competent open complexes, and initiation of RNA synthesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Fidaxomicin versus vancomycin for Clostridium difficile infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Multiple roles of the RNA polymerase {beta}' SW2 region in transcription initiation, promoter escape, and RNA elongation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Myxopyronin: a punch in the jaws of bacterial RNA polymerase.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Tie me up, tie me down: inhibiting RNA polymerase

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Progress in targeting bacterial transcription

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

In vitro activity of OPT-80 against Clostridium difficile

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Elongation by RNA polymerase II: structure-function relationship

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Multisubunit RNA polymerases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Measures of susceptibility from a spiral gradient of drug concentrations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Initiation of transcription in vitro is inhibited by lipiarmycin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lipiarmycin: An antibiotic inhibiting nucleic acid polymerases

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Characterization of a Sugar-O-methyltransferase TiaS5 Affords New Tiacumicin Analogues with Improved Antibacterial Properties and Reveals Substrate Promiscuity

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Characterization of Tiacumicin B Biosynthetic Gene Cluster Affording Diversified Tiacumicin Analogues and Revealing a Tailoring Dihalogenase

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Biosynthesis of the myxobacterial antibiotic corallopyronin A.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Lost in transcription--inhibition of RNA polymerase

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycin

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196380

Production of brominated tiacumicin derivatives

28 November 2018

1 reference

12 December 2020

Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitro

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

1 reference

12 December 2020

A fluorescence-based assay for multisubunit DNA-dependent RNA polymerases

1 reference

12 December 2020

Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS

1 reference

12 December 2020

Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action

1 reference

12 December 2020

Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties

1 reference

12 December 2020

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review

1 reference

12 December 2020

The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria

1 reference

12 December 2020

Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination

1 reference

12 December 2020

Fidaxomicin approved for C. difficile infections

1 reference

12 December 2020

The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria

1 reference

12 December 2020

Antibiotika aus Gleitenden Bakterien, XVII. Myxopyronin A und B – zwei neue Antibiotika ausMyxococcus fulvus Stamm Mx f50

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Antibiotics from Gliding Bacteria, LXXVIII. Ripostatin A, B, and C: Isolation and Structure and Structure Elucidation of Novel Metabolites fromSorangium cellulosum

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Structure elucidation of the macrocyclic antibiotic lipiarmycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

1 reference

7 January 2021

Fidaxomicin: first-in-class macrocyclic antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, bilogical and biochemical characterization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

Production of Brominated Tiacumicin Derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MIB.2011.07.030

7 January 2021

10.1016/J.MIB.2011.07.030

Identifiers

DOI

1 reference

2602857

2602857

1 reference

1 reference

1 reference